India Life Sciences Fund, a healthcare and pharmaceuticals-focused private equity fund managed by InvAscent, has completed with $250 million in funding for its third growth capital fund.
The investments came from investors including blue-chip fund-of-fund vehicles, pension funds, university endowments and family offices from the U.S. and Europe.
The new fund will make investments between ticket size of $10 million to $50 million.
India Life Sciences Fund said that it has already made three commitments from the third fund.